Clinical Outcomes of Intracardiac Echocardiography-Guided Contrast Agent-Free Cryoballoon Ablation in Atrial Fibrillation Patients With Renal Insufficiency
- PMID: 38111185
- PMCID: PMC10961213
- DOI: 10.4070/kcj.2023.0194
Clinical Outcomes of Intracardiac Echocardiography-Guided Contrast Agent-Free Cryoballoon Ablation in Atrial Fibrillation Patients With Renal Insufficiency
Abstract
Background and objectives: Previous studies have reported an association between impaired renal function and poor outcomes after radiofrequency catheter ablation in patients with atrial fibrillation (AF). However, outcomes of cryoballoon ablation (CBA) in patients with renal insufficiency are not fully elucidated. This study aimed to compare outcomes of CBA in AF patients with chronic kidney disease (CKD) versus those without CKD and to assess changes in renal function over 12 months following CBA.
Methods: A total of 839 patients (65.1% with non-paroxysmal AF [PAF]) who underwent de novo CBA were prospectively enrolled. We divided patients into two groups based on creatinine clearance rate (CCr) and performed intracardiac echocardiography (ICE)-guided contrast agent-free CBA.
Results: In comparison with patients without CKD (CCr >50, n=722), those with CKD (CCr ≤50, n=117) were older and predominantly female, had a lower body mass index, and showed a higher prevalence of heart failure and hypertension. Mean CHA2DS2-VAS score was significantly higher in CKD group than in non-CKD group. Procedure-related complications were not significantly different between two groups. During a mean follow-up period of 25.4±11.9 months, clinical recurrence occurred in 182 patients (21.7%) and not significantly different between two groups. In multivariate analysis, non-PAF and left atrial size were independent predictors of AF recurrence. CCr levels significantly improved over 12 months after CBA in CKD group.
Conclusions: ICE-guided contrast-agent-free CBA showed comparable long-term clinical outcomes without increasing procedure-related complications and improvement of renal function over 12 months following CBA in AF patients with CKD.
Keywords: Ablation; Atrial fibrillation; Echocardiography; Renal insufficiency.
Copyright © 2024. The Korean Society of Cardiology.
Conflict of interest statement
The authors have no financial conflict of interest.
Figures



Similar articles
-
The effect of left atrial remodeling after cryoballoon ablation and radiofrequency ablation for paroxysmal atrial fibrillation.Clin Cardiol. 2021 Jan;44(1):78-84. doi: 10.1002/clc.23507. Epub 2020 Nov 18. Clin Cardiol. 2021. PMID: 33205849 Free PMC article.
-
Safety and efficacy of intracardiac echocardiography-guided zero-fluoroscopic cryoballoon ablation for atrial fibrillation: a prospective randomized controlled trial.Europace. 2023 May 19;25(5):euad086. doi: 10.1093/europace/euad086. Europace. 2023. PMID: 37021403 Free PMC article. Clinical Trial.
-
The impact of early cryoballoon ablation on clinical outcome in patients with atrial fibrillation: From the Korean cryoballoon ablation registry.J Cardiovasc Electrophysiol. 2024 Jan;35(1):69-77. doi: 10.1111/jce.16122. Epub 2023 Nov 5. J Cardiovasc Electrophysiol. 2024. PMID: 37927151
-
A systematic review and meta-analysis comparing second-generation cryoballoon and contact force radiofrequency ablation for initial ablation of paroxysmal and persistent atrial fibrillation.J Cardiovasc Electrophysiol. 2020 Oct;31(10):2559-2571. doi: 10.1111/jce.14676. Epub 2020 Jul 23. J Cardiovasc Electrophysiol. 2020. PMID: 32671920
-
Efficacy and safety of visually guided laser balloon versus cryoballoon ablation for paroxysmal atrial fibrillation: a systematic review and meta-analysis.Front Cardiovasc Med. 2023 Aug 22;10:1229223. doi: 10.3389/fcvm.2023.1229223. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37674807 Free PMC article. Review.
Cited by
-
Is ICE-Guided Cryoballoon Ablation for Atrial Fibrillation a New Advancement?Korean Circ J. 2024 Mar;54(3):124-125. doi: 10.4070/kcj.2024.0041. Korean Circ J. 2024. PMID: 38506102 Free PMC article. No abstract available.
-
The use of Intracardiac Echocardiography in Catheter Ablation of Atrial Fibrillation.Curr Cardiol Rep. 2024 Sep;26(9):893-901. doi: 10.1007/s11886-024-02091-w. Epub 2024 Jul 12. Curr Cardiol Rep. 2024. PMID: 38995505 Review.
References
-
- Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893–2962. - PubMed
-
- Boriani G, Savelieva I, Dan GA, et al. Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. Europace. 2015;17:1169–1196. - PMC - PubMed
-
- Haïssaguerre M, Jaïs P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659–666. - PubMed
-
- Khan AR, Khan S, Sheikh MA, Khuder S, Grubb B, Moukarbel GV. Catheter ablation and antiarrhythmic drug therapy as first- or second-line therapy in the management of atrial fibrillation: systematic review and meta-analysis. Circ Arrhythm Electrophysiol. 2014;7:853–860. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources